In acute central retinal artery occlusion treated within 4.5 hours after onset, intravenous tenecteplase did not result in greater recovery of vision at 30 days than aspirin and was associated with serious safety concerns.
Emergency Medicine
|11th Mar, 2026
|The New England Journal of Medicine
Emergency Medicine
|11th Mar, 2026
|The New England Journal of Medicine
Emergency Medicine
|11th Mar, 2026
|The New England Journal of Medicine
Emergency Medicine
|11th Mar, 2026
|The New England Journal of Medicine
Emergency Medicine
|11th Mar, 2026
|The New England Journal of Medicine
Emergency Medicine
|11th Mar, 2026
|The New England Journal of Medicine
Emergency Medicine
|11th Mar, 2026
|The New England Journal of Medicine